# Industrial Logistics Properties Trust: financial statements, quarterly

ILPT · Nasdaq · CIK 1717307 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ilpt.md) · [Financials](/companies/ilpt/financials.md) · [Filings](/companies/ilpt/filings.md) · [Insiders](/companies/ilpt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ilpt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [72.9](/filings/0001717307-23-000049.md) | [73.0 d](/filings/0001717307-24-000010.md) | [73.2](/filings/0001717307-24-000018.md) | [73.6](/filings/0001717307-25-000028.md) | [73.9](/filings/0001717307-25-000038.md) | [71.7 d](/filings/0001717307-26-000012.md) | [69.8](/filings/0001717307-26-000027.md) | [67.9](/filings/0001717307-26-000041.md) | [63.5](/filings/0001717307-25-000038.md) | [63.4 d](/filings/0001717307-26-000012.md) | [61.7](/filings/0001717307-26-000027.md) | [61.1](/filings/0001717307-26-000041.md) |
| Income tax | $m | [0.1](/filings/0001717307-24-000038.md) | [(0.0) d](/filings/0001717307-26-000012.md) | [0.0](/filings/0001717307-25-000016.md) | [0.0](/filings/0001717307-25-000028.md) | [0.0](/filings/0001717307-25-000038.md) | [0.1 d](/filings/0001717307-26-000012.md) | [0.0](/filings/0001717307-26-000027.md) | [0.0](/filings/0001717307-26-000041.md) | [0.0](/filings/0001717307-25-000038.md) | [0.0 d](/filings/0001717307-26-000012.md) | [0.1](/filings/0001717307-26-000027.md) | [0.1](/filings/0001717307-26-000041.md) |
| Net income | $m | [(26.1)](/filings/0001717307-24-000038.md) | [(31.2) d](/filings/0001717307-26-000012.md) | [(23.4)](/filings/0001717307-25-000016.md) | [(23.2)](/filings/0001717307-25-000028.md) | [(25.0)](/filings/0001717307-25-000038.md) | [(24.1) d](/filings/0001717307-26-000012.md) | [(21.5)](/filings/0001717307-26-000027.md) | [(21.3)](/filings/0001717307-26-000041.md) | [(21.6)](/filings/0001717307-25-000038.md) | [(1.8) d](/filings/0001717307-26-000012.md) | [(9.4)](/filings/0001717307-26-000027.md) | [(14.5)](/filings/0001717307-26-000041.md) |
| Diluted EPS | $ per share | [(0.40)](/filings/0001717307-24-000038.md) | not reported | [(0.36)](/filings/0001717307-25-000016.md) | [(0.35)](/filings/0001717307-25-000028.md) | [(0.38)](/filings/0001717307-25-000038.md) | not reported | [(0.33)](/filings/0001717307-26-000027.md) | [(0.32)](/filings/0001717307-26-000041.md) | [(0.33)](/filings/0001717307-25-000038.md) | not reported | [(0.14)](/filings/0001717307-26-000027.md) | [(0.22)](/filings/0001717307-26-000041.md) |
| Basic EPS | $ per share | [(0.40)](/filings/0001717307-24-000038.md) | not reported | [(0.36)](/filings/0001717307-25-000016.md) | [(0.35)](/filings/0001717307-25-000028.md) | [(0.38)](/filings/0001717307-25-000038.md) | not reported | [(0.33)](/filings/0001717307-26-000027.md) | [(0.32)](/filings/0001717307-26-000041.md) | [(0.33)](/filings/0001717307-25-000038.md) | not reported | [(0.14)](/filings/0001717307-26-000027.md) | [(0.22)](/filings/0001717307-26-000041.md) |

- Revenue: not reported
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [83.3](/filings/0001717307-24-000038.md) | [112](/filings/0001717307-26-000012.md) | [128](/filings/0001717307-25-000016.md) | [146](/filings/0001717307-25-000028.md) | [154](/filings/0001717307-25-000038.md) | [132](/filings/0001717307-26-000012.md) | [108](/filings/0001717307-26-000027.md) | [58.6](/filings/0001717307-26-000041.md) | [83.2](/filings/0001717307-25-000038.md) | [94.8](/filings/0001717307-26-000041.md) | [99.5](/filings/0001717307-26-000027.md) | [135](/filings/0001717307-26-000041.md) |
| Total assets | $m | [5,634](/filings/0001717307-23-000049.md) | [5,564](/filings/0001717307-25-000009.md) | [5,528](/filings/0001717307-24-000018.md) | [5,490](/filings/0001717307-24-000030.md) | [5,455](/filings/0001717307-24-000038.md) | [5,406](/filings/0001717307-26-000012.md) | [5,364](/filings/0001717307-25-000016.md) | [5,239](/filings/0001717307-25-000028.md) | [5,219](/filings/0001717307-25-000038.md) | [5,190](/filings/0001717307-26-000041.md) | [5,167](/filings/0001717307-26-000027.md) | [5,123](/filings/0001717307-26-000041.md) |
| Total liabilities | $m | [4,416](/filings/0001717307-23-000049.md) | [4,402](/filings/0001717307-25-000009.md) | [4,405](/filings/0001717307-24-000018.md) | [4,402](/filings/0001717307-24-000030.md) | [4,412](/filings/0001717307-24-000038.md) | [4,397](/filings/0001717307-26-000012.md) | [4,387](/filings/0001717307-25-000016.md) | [4,291](/filings/0001717307-25-000028.md) | [4,305](/filings/0001717307-25-000038.md) | [4,289](/filings/0001717307-26-000041.md) | [4,283](/filings/0001717307-26-000027.md) | [4,282](/filings/0001717307-26-000041.md) |
| Long-term debt | $m | [4,304](/filings/0001717307-23-000049.md) | [4,306](/filings/0001717307-25-000009.md) | [4,308](/filings/0001717307-24-000018.md) | [4,307](/filings/0001717307-24-000030.md) | [4,305](/filings/0001717307-24-000038.md) | [4,301](/filings/0001717307-26-000012.md) | [4,296](/filings/0001717307-25-000016.md) | [4,200](/filings/0001717307-25-000028.md) | [4,197](/filings/0001717307-25-000038.md) | [4,193](/filings/0001717307-26-000041.md) | [4,189](/filings/0001717307-26-000027.md) | [4,184](/filings/0001717307-26-000041.md) |
| Shareholders' equity | $m | [714](/filings/0001717307-23-000049.md) | [670](/filings/0001717307-25-000009.md) | [643](/filings/0001717307-24-000018.md) | [618](/filings/0001717307-24-000030.md) | [586](/filings/0001717307-24-000038.md) | [562](/filings/0001717307-26-000012.md) | [540](/filings/0001717307-25-000016.md) | [519](/filings/0001717307-25-000028.md) | [494](/filings/0001717307-25-000038.md) | [490](/filings/0001717307-26-000041.md) | [480](/filings/0001717307-26-000027.md) | [462](/filings/0001717307-26-000041.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3.4 d](/filings/0001717307-24-000038.md) | [(8.0) d](/filings/0001717307-26-000012.md) | [8.0](/filings/0001717307-25-000016.md) | [10.9 d](/filings/0001717307-25-000028.md) | [(3.4) d](/filings/0001717307-25-000038.md) | [(13.5) d](/filings/0001717307-26-000012.md) | [11.4](/filings/0001717307-26-000027.md) | [18.4 d](/filings/0001717307-26-000041.md) | [22.7 d](/filings/0001717307-25-000038.md) | [8.2 d](/filings/0001717307-26-000012.md) | [15.9](/filings/0001717307-26-000027.md) | [22.0 d](/filings/0001717307-26-000041.md) |
| Dividends paid | $m | [0.7 d](/filings/0001717307-24-000038.md) | [0.7 d](/filings/0001717307-26-000012.md) | [0.7](/filings/0001717307-25-000016.md) | [0.7 d](/filings/0001717307-25-000028.md) | [0.7 d](/filings/0001717307-25-000038.md) | [0.7 d](/filings/0001717307-26-000012.md) | [0.7](/filings/0001717307-26-000027.md) | [0.7 d](/filings/0001717307-26-000041.md) | [3.3 d](/filings/0001717307-25-000038.md) | [3.3 d](/filings/0001717307-26-000012.md) | [3.3](/filings/0001717307-26-000027.md) | [3.3 d](/filings/0001717307-26-000041.md) |
| Share repurchases | $m | [0.1 d](/filings/0001717307-24-000038.md) | [0.0 d](/filings/0001717307-26-000012.md) | [0.0](/filings/0001717307-25-000016.md) | [0.0 d](/filings/0001717307-25-000028.md) | [0.3 d](/filings/0001717307-25-000038.md) | [0.0 d](/filings/0001717307-26-000012.md) | [0.0](/filings/0001717307-26-000027.md) | [0.0 d](/filings/0001717307-26-000041.md) | [0.4 d](/filings/0001717307-25-000038.md) | [0.0 d](/filings/0001717307-26-000012.md) | [0.0](/filings/0001717307-26-000027.md) | [0.0 d](/filings/0001717307-26-000041.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [65.3](/filings/0001717307-23-000049.md) | [65.3](/filings/0001717307-24-000018.md) | [65.4](/filings/0001717307-24-000030.md) | [65.5](/filings/0001717307-24-000038.md) | [65.6](/filings/0001717307-25-000016.md) | [65.6](/filings/0001717307-25-000028.md) | [65.8](/filings/0001717307-25-000038.md) | [65.8](/filings/0001717307-26-000027.md) | [65.9](/filings/0001717307-26-000041.md) | [66.1](/filings/0001717307-25-000038.md) | [66.2](/filings/0001717307-26-000027.md) | [66.2](/filings/0001717307-26-000041.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 66,745,881 at 2026-07-27, from the cover of the [10-Q filed 2026-07-29](/filings/0001717307-26-000041.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.